摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl (2S,3aR,7aR)-1-benzyl-6-oxooctahydroindole-2-carboxylate | 181649-49-0

中文名称
——
中文别名
——
英文名称
benzyl (2S,3aR,7aR)-1-benzyl-6-oxooctahydroindole-2-carboxylate
英文别名
(2S,3aR,7aR)-1-benzyl-6-oxo-octahydroindole-2-carboxylic acid benzyl ester;benzyl (2S,3aR,7aR)-1-benzyl-6-oxo-3,3a,4,5,7,7a-hexahydro-2H-indole-2-carboxylate
benzyl (2S,3aR,7aR)-1-benzyl-6-oxooctahydroindole-2-carboxylate化学式
CAS
181649-49-0
化学式
C23H25NO3
mdl
——
分子量
363.456
InChiKey
NZZOYIBQDBXYNF-FCEUIQTBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    503.6±40.0 °C(Predicted)
  • 密度:
    1.192±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    benzyl (2S,3aR,7aR)-1-benzyl-6-oxooctahydroindole-2-carboxylatepalladium dihydroxide Dowex 1XB 、 氢气L-Selectride 作用下, 以 四氢呋喃 为溶剂, 生成 methyl (2S,3aR,6S,7aR)-1-acetyl-6-hydroxy-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylate
    参考文献:
    名称:
    Synthesis of the octahydroindole core of aeruginosins: a new bicyclic α-amino acid
    摘要:
    The first synthesis of 6-hydroxyoctahydroindole-2-carboxylic acid derivatives with a cis fusion in the azabicyclic nucleus is described. The synthesis involves a Birch reduction of O-methyl-L-tyrosine followed by an aminocyclization in acid medium to give a mixture of 6-oxo-octahydroindole-2-carboxylic acids 3 and 4, which could be separated after dibenzylation. Transesterification, hydrogenolysis in the presence of acetic anhydride and reduction of the amido ketones 9 and 10 provides the four stereoisomeric alcohols from which alcohol 14 showed nmr data very close to the aeruginosin 298-A core. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0957-4166(96)00225-x
  • 作为产物:
    描述:
    lithium 2-amino-3-(4-methoxycyclohexa-1,4-dienyl)propanoate 、 溴甲苯盐酸碳酸氢钠 作用下, 以 乙醇 为溶剂, 反应 15.0h, 以27%的产率得到benzyl (2S,3aR,7aR)-1-benzyl-6-oxooctahydroindole-2-carboxylate
    参考文献:
    名称:
    [EN] [B]-FUSED BICYCLIC PROLINE DERIVATIVES AND THEIR USE FOR TREATING ARTHRITIC CONDITIONS
    [FR] DERIVES BICYCLIQUES [B]-FUSIONNES DE PROLINE ET LEUR UTILISATION POUR TRAITER DES ETATS ARTHRITIQUES
    摘要:
    该发明涉及一种[b]-融合双环脯氨酸衍生物,或其药用盐;包括该化合物或其盐的药物组合物;以及治疗疾病的方法,包括但不限于预防或抑制关节软骨损伤,预防或治疗以关节软骨损伤、关节炎或关节疼痛为特征的疾病的方法。[b]-融合双环脯氨酸衍生物是上述化合物的I式化合物。以关节软骨损伤或关节疼痛为特征的疾病包括骨关节炎和类风湿性关节炎。类风湿性关节炎也以关节炎为特征。该发明还涉及合成和制备[b]-融合双环脯氨酸衍生物或其药用盐的方法。
    公开号:
    WO2004092132A1
点击查看最新优质反应信息

文献信息

  • Synthesis of the octahydroindole unit of aeruginosins via asymmetric hydrogenation of the Diels–Alder adducts of 2-amido-2,4-pentadienoate
    作者:Yoichiro Hoshina、Takayuki Doi、Takashi Takahashi
    DOI:10.1016/j.tet.2007.09.078
    日期:2007.12
    An optically active octahydroindole, the core unit of aeruginosins (Choi) was synthesized. The Diels–Alder reaction of Danishefsky's diene with methyl (Z)-2-acetamido-2,4-pentadienoates provided the adducts regioselectively in good yield. The adducts were converted to the l-Choi precursor by asymmetric hydrogenation, followed by acid cyclization.
    合成了一种光学活性的八氢吲哚,它是铜绿素酶(Choi)的核心单元。Danishefsky的二烯与(Z)-2-乙酰氨基-2,4-戊二烯酸甲酯的Diels-Alder反应提供了良好的区域选择性加合物。通过不对称氢化,然后酸环化,将加合物转化为1-Choi前体。
  • First Total Syntheses of Aeruginosin 298-A and Aeruginosin 298-B, Based on a Stereocontrolled Route to the New Amino Acid 6-Hydroxyoctahydroindole-2-carboxylic Acid
    作者:Nativitat Valls、Meritxell López-Canet、Mercè Vallribera、Josep Bonjoch
    DOI:10.1002/1521-3765(20010817)7:16<3446::aid-chem3446>3.0.co;2-0
    日期:2001.8.17
    The first total syntheses of aeruginosin 298-A (1) and aeruginosin 298-B (3) are described. The syntheses of the alternative putative structures 2 and 4 were also accomplished. The key common strategic element is the stereo-controlled synthesis of (2S,3aS,6R,7aS)-6-hydroxyoctahydroindole-2-carboxylic acid (L-Choi, 5) from L-tyrosine. The synthesis of this new bicyclic alpha-amino acid, which is the core
    描述了铜绿素298-A(1)和铜绿素298-B(3)的第一批合成。还完成了备选推定结构2和4的合成。关键的共同战略要素是从L-酪氨酸立体控制合成(2S,3aS,6R,7aS)-6-羟基八氢吲哚-2-羧酸(L-Choi,5)。作为铜绿素酶的核心,这种新的双环α-氨基酸的合成涉及桦木还原O-甲基-L-酪氨酸(6)和在酸性介质中将所得的二氢茴香醚7进行氨基环化,然后进行N-苄基化,得到非对映异构体12和13。用HCl-MeOH酸处理后,最后两个产生平衡混合物,其中内异构体13明显占优势。在(Boc)2O存在下加氢13得到16,经LS-Selectride还原后,可提供醇22(一种受保护的L-Choi)。22与D-亮氨酸,受保护的(R)-(4-羟苯基)乳酸和L-精氨酸片段的连续偶联,然后降低至精氨酸水平和脱保护的最终步骤完成了合成序列,产生了铜绿素酶298-A (1)。光谱比较显示,肽2具有先前针
  • [B]-fused bicyclic proline derivatives and their use for treating arthritic conditions
    申请人:Barvian C. Nicole
    公开号:US20050143427A1
    公开(公告)日:2005-06-30
    This invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.
    本发明涉及一种[b]-融合的双环脯氨酸衍生物,或其药学上可接受的盐;包括该化合物或其盐的制药组合物,以及治疗疾病的方法,包括但不限于预防或抑制关节软骨损伤和预防或治疗以关节软骨损伤、关节炎或关节疼痛为特征的疾病的方法。[b]-融合的双环脯氨酸衍生物是如上所述的式I的化合物。以关节软骨损伤或关节疼痛为特征的疾病包括骨关节炎和类风湿性关节炎等。类风湿性关节炎也以关节炎为特征。本发明还涉及合成和制备[b]-融合的双环脯氨酸衍生物或其药学上可接受的盐的方法。
  • [EN] [B]-FUSED BICYCLIC PROLINE DERIVATIVES AND THEIR USE FOR TREATING ARTHRITIC CONDITIONS<br/>[FR] DERIVES BICYCLIQUES [B]-FUSIONNES DE PROLINE ET LEUR UTILISATION POUR TRAITER DES ETATS ARTHRITIQUES
    申请人:WARNER LAMBERT CO
    公开号:WO2004092132A1
    公开(公告)日:2004-10-28
    The invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.
    该发明涉及一种[b]-融合双环脯氨酸衍生物,或其药用盐;包括该化合物或其盐的药物组合物;以及治疗疾病的方法,包括但不限于预防或抑制关节软骨损伤,预防或治疗以关节软骨损伤、关节炎或关节疼痛为特征的疾病的方法。[b]-融合双环脯氨酸衍生物是上述化合物的I式化合物。以关节软骨损伤或关节疼痛为特征的疾病包括骨关节炎和类风湿性关节炎。类风湿性关节炎也以关节炎为特征。该发明还涉及合成和制备[b]-融合双环脯氨酸衍生物或其药用盐的方法。
  • Synthesis of the octahydroindole core of aeruginosins: a new bicyclic α-amino acid
    作者:Josep Bonjoch、Juanlo Catena、Esther Isábal、Meritxell López-Canet、Nativitat Valls
    DOI:10.1016/0957-4166(96)00225-x
    日期:1996.7
    The first synthesis of 6-hydroxyoctahydroindole-2-carboxylic acid derivatives with a cis fusion in the azabicyclic nucleus is described. The synthesis involves a Birch reduction of O-methyl-L-tyrosine followed by an aminocyclization in acid medium to give a mixture of 6-oxo-octahydroindole-2-carboxylic acids 3 and 4, which could be separated after dibenzylation. Transesterification, hydrogenolysis in the presence of acetic anhydride and reduction of the amido ketones 9 and 10 provides the four stereoisomeric alcohols from which alcohol 14 showed nmr data very close to the aeruginosin 298-A core. Copyright (C) 1996 Elsevier Science Ltd
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物